Literature DB >> 3896096

The satiety effect of cholecystokinin. Recent progress and current problems.

G P Smith, J Gibbs.   

Abstract

Since the discovery of the satiety effect of CCK in 1973, progress has been made and problems have been encountered. The progress has included the accumulation of strong, indirect evidence that exogenous CCK acts in the abdomen to activate vagal afferent fibers and that exogenous CCK may be useful in the treatment of bulimia and obesity in humans. The most pressing problem is the current lack of evidence for the hypothesis that the satiety effect of exogenous CCK reveals a physiological function of endogenous CCK released by food entering the small intestine during a meal. Since clarification of this problem and exploitation of the current progress seem possible with current ideas and techniques, the satiety effect of CCK should continue to receive considerable experimental attention.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3896096     DOI: 10.1111/j.1749-6632.1985.tb29936.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  14 in total

Review 1.  Changes in the plasma membrane in metabolic disease: impact of the membrane environment on G protein-coupled receptor structure and function.

Authors:  Aditya J Desai; Laurence J Miller
Journal:  Br J Pharmacol       Date:  2017-08-03       Impact factor: 8.739

2.  Cholecystokinin responsiveness varies across the population dependent on metabolic phenotype.

Authors:  Aditya J Desai; Maoqing Dong; Blake T Langlais; Amylou C Dueck; Laurence J Miller
Journal:  Am J Clin Nutr       Date:  2017-06-07       Impact factor: 7.045

3.  Impact of ursodeoxycholic acid on a CCK1R cholesterol-binding site may contribute to its positive effects in digestive function.

Authors:  Aditya J Desai; Maoqing Dong; Kaleeckal G Harikumar; Laurence J Miller
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-07-02       Impact factor: 4.052

4.  Elimination of a cholecystokinin receptor agonist 'trigger' in an effort to develop positive allosteric modulators without intrinsic agonist activity.

Authors:  Aditya J Desai; Brad R Henke; Laurence J Miller
Journal:  Bioorg Med Chem Lett       Date:  2015-03-24       Impact factor: 2.823

5.  Screening for positive allosteric modulators of cholecystokinin type 1 receptor potentially useful for management of obesity.

Authors:  Daniela G Dengler; Qing Sun; Kaleeckal G Harikumar; Laurence J Miller; Eduard A Sergienko
Journal:  SLAS Discov       Date:  2022-07-16       Impact factor: 3.341

6.  Molecular Mechanism of Action of Triazolobenzodiazepinone Agonists of the Type 1 Cholecystokinin Receptor. Possible Cooperativity across the Receptor Homodimeric Complex.

Authors:  Aditya J Desai; Polo C H Lam; Andrew Orry; Ruben Abagyan; Arthur Christopoulos; Patrick M Sexton; Laurence J Miller
Journal:  J Med Chem       Date:  2015-12-10       Impact factor: 7.446

Review 7.  Therapeutic potential for novel drugs targeting the type 1 cholecystokinin receptor.

Authors:  Erin E Cawston; Laurence J Miller
Journal:  Br J Pharmacol       Date:  2009-11-18       Impact factor: 8.739

8.  A type 1 cholecystokinin receptor mutant that mimics the dysfunction observed for wild type receptor in a high cholesterol environment.

Authors:  Aditya J Desai; Kaleeckal G Harikumar; Laurence J Miller
Journal:  J Biol Chem       Date:  2014-05-13       Impact factor: 5.157

Review 9.  Roles of Cholecystokinin in the Nutritional Continuum. Physiology and Potential Therapeutics.

Authors:  Laurence J Miller; Kaleeckal G Harikumar; Denise Wootten; Patrick M Sexton
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-02       Impact factor: 5.555

10.  Sensitivity of cholecystokinin receptors to membrane cholesterol content.

Authors:  Aditya J Desai; Laurence J Miller
Journal:  Front Endocrinol (Lausanne)       Date:  2012-10-18       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.